Meanwhile previous studies confirmed a significant association between the IL-1 polymorphisms and increased risk for tumor development in patients with intestinal type or diffuse gastric carcinoma with an odds ratio of 2.7 for carriers of IL-1 (gene 1B-511T) [18]. This evidence concerns the gene IL1B and neoplasm.